Vaccination rates across the country have continued to fall since the height of the pandemic, but the coronavirus never ...

U.S. equities were mixed at midday after China accused the U.S. of violating a trade deal the two countries reached last month.

Moderna was recently told that the Health and Human Services Department (HHS) had withdrawn a $766million grant awarded by ...

Federal health officials have pulled back a key recommendation that pregnant women get the COVID-19 vaccine, causing criticism from experts.

The new mRNA vaccine encodes the receptor-binding domain and the N-terminal domain of the SARS-CoV-2 spike protein ...

From eligibility to dosage and future rollout, here’s what you need to know about the FDA’s latest vaccine approval.

FDA approves Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk groups Phase 3 trial shows mNEXSPIKE outperforms original ...

Moderna has withdrawn the BLA for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after consulting with FDA.

The FDA approved Moderna’s new Covid-19 vaccine late Friday, though it placed restrictions on its use that the company’s ...

Despite uncertainties arising from new FDA policies around COVID-19 vaccines, Moderna has cleared the agency's desk with its ...

Practices can delabel other suspected drug allergies while assessing patients for allergies to COVID-19 vaccines, according to a study published in Vaccine. This program can improve health-related ...